SEC Form 4 research
| Issuer | Vanda Pharmaceuticals Inc. |
|---|---|
| Tickers | VNDA |
| Reporting owners | 81 |
| Officers and directors | 22 |
| Last public filing | 2026-11-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-05 | 2026-11-05 | Duncan Charles Cliff | P | 5,803 | $3.8 | Not reported |
| 2026-11-05 | 2026-11-04 | Duncan Charles Cliff | P | 3,447 | $3.82 | Not reported |
| 2026-11-05 | 2026-11-03 | Duncan Charles Cliff | P | 750 | $3.8 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.